LGBT Cancer Project

Therapeutic Areas: Oncology | Nephrology | Family Medicine

Renal Cell Carcinoma Clinical Trials

A listing of Renal Cell Carcinoma medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Alabama

UPDATED

Birmingham Alabama 35205

Patients are needed to participate in a clinical research study of Nivolumab, Ipilimumab and Placebo to evaluate Renal Cell Carcinoma

Arizona

UPDATED

Tucson Arizona 85711

Patients are needed to participate in a clinical research study evaluating Pembrolizumab for the treatment of Renal Cell Carcinoma

Arkansas

UPDATED

Fayetteville Arkansas 72703

Patients are needed to participate in a clinical research study of Nivolumab, Ipilimumab and Placebo to evaluate Renal Cell Carcinoma

District of Columbia

UPDATED

Washington District of Columbia 20037

Patients are needed to participate in a clinical research study evaluating Pembrolizumab for the treatment of Renal Cell Carcinoma

UPDATED

Washington District of Columbia 20007

Patients are needed to participate in a clinical research study evaluating Pembrolizumab for the treatment of Renal Cell Carcinoma

Florida

UPDATED

Miami Florida 33143

Patients are needed to participate in a clinical research study evaluating Pembrolizumab for the treatment of Renal Cell Carcinoma

Georgia

UPDATED

Athens Georgia 30607

Patients are needed to participate in a clinical research study of Nivolumab, Ipilimumab and Placebo to evaluate Renal Cell Carcinoma

Illinois

UPDATED

Chicago Illinois 60637

Patients are needed to participate in a clinical research study evaluating Pembrolizumab for the treatment of Renal Cell Carcinoma

Louisiana

UPDATED

New Orleans Louisiana 70112

Patients are needed to participate in a clinical research study evaluating Pembrolizumab for the treatment of Renal Cell Carcinoma

Massachusetts

UPDATED

Boston Massachusetts 02215

Patients are needed to participate in a clinical research study evaluating Pembrolizumab for the treatment of Renal Cell Carcinoma

UPDATED

Boston Massachusetts 02215

Patients are needed to participate in a clinical research study evaluating Pembrolizumab for the treatment of Renal Cell Carcinoma

Michigan

UPDATED

Detroit Michigan 48202

Patients are needed to participate in a clinical research study evaluating Pembrolizumab for the treatment of Renal Cell Carcinoma

Missouri

UPDATED

St. Louis Missouri 63110

Patients are needed to participate in a clinical research study of Nivolumab, Ipilimumab and Placebo to evaluate Renal Cell Carcinoma

Montana

UPDATED

Billings Montana 59102

Patients are needed to participate in a clinical research study evaluating Pembrolizumab for the treatment of Renal Cell Carcinoma

Nevada

UPDATED

Las Vegas Nevada 89169

Patients are needed to participate in a clinical research study evaluating Pembrolizumab for the treatment of Renal Cell Carcinoma

New Jersey

UPDATED

Neptune City New Jersey 07753-4859

Patients are needed to participate in a clinical research study of Nivolumab, Ipilimumab and Placebo to evaluate Renal Cell Carcinoma

New York

UPDATED

New York New York 10016

Patients are needed to participate in a clinical research study evaluating Pembrolizumab for the treatment of Renal Cell Carcinoma

UPDATED

New York New York 10065

Patients are needed to participate in a clinical research study of Nivolumab, Ipilimumab and Placebo to evaluate Renal Cell Carcinoma

Pennsylvania

UPDATED

Philadelphia Pennsylvania 19111

Patients are needed to participate in a clinical research study evaluating Pembrolizumab for the treatment of Renal Cell Carcinoma

South Carolina

UPDATED

Charleston South Carolina 29414

Patients are needed to participate in a clinical research study evaluating Pembrolizumab for the treatment of Renal Cell Carcinoma

UPDATED

Greenville South Carolina 29607

Patients are needed to participate in a clinical research study of Nivolumab, Ipilimumab and Placebo to evaluate Renal Cell Carcinoma

Tennessee

UPDATED

Chattanooga Tennessee 37403

Patients are needed to participate in a clinical research study evaluating Pembrolizumab for the treatment of Renal Cell Carcinoma

UPDATED

Chattanooga Tennessee 37403

Patients are needed to participate in a clinical research study of Nivolumab, Ipilimumab and Placebo to evaluate Renal Cell Carcinoma

Vermont

UPDATED

Burlington Vermont 05401

Patients are needed to participate in a clinical research study evaluating Pembrolizumab for the treatment of Renal Cell Carcinoma

Virginia

UPDATED

Fairfax Virginia 22031

Patients are needed to participate in a clinical research study of Nivolumab, Ipilimumab and Placebo to evaluate Renal Cell Carcinoma

UPDATED

Roanoke Virginia 24014

Patients are needed to participate in a clinical research study evaluating Pembrolizumab for the treatment of Renal Cell Carcinoma

Washington

UPDATED

Kennewick Washington 99336

Patients are needed to participate in a clinical research study evaluating Pembrolizumab for the treatment of Renal Cell Carcinoma

UPDATED

Seattle Washington 98109

Patients are needed to participate in a clinical research study evaluating Pembrolizumab for the treatment of Renal Cell Carcinoma

Wisconsin

UPDATED

Milwaukee Wisconsin 53226

Patients are needed to participate in a clinical research study evaluating Pembrolizumab for the treatment of Renal Cell Carcinoma

Canada

UPDATED

Kirkland Quebec H9H 4M7

Patients are needed to participate in a clinical research study evaluating Pembrolizumab for the treatment of Renal Cell Carcinoma

Czechia

UPDATED

Prague Prague 6

Patients are needed to participate in a clinical research study evaluating Pembrolizumab for the treatment of Renal Cell Carcinoma

Denmark

UPDATED

Glostrup

Patients are needed to participate in a clinical research study evaluating Pembrolizumab for the treatment of Renal Cell Carcinoma

France

UPDATED

La Roche sur Yon 85320

Patients are needed to participate in a clinical research study of Nivolumab, Ipilimumab and Placebo to evaluate Renal Cell Carcinoma

Germany

UPDATED

Aachen 52074

Patients are needed to participate in a clinical research study of Nivolumab, Ipilimumab and Placebo to evaluate Renal Cell Carcinoma

UPDATED

Haar

Patients are needed to participate in a clinical research study evaluating Pembrolizumab for the treatment of Renal Cell Carcinoma

UPDATED

Hamburg 22763

Patients are needed to participate in a clinical research study of Nivolumab, Ipilimumab and Placebo to evaluate Renal Cell Carcinoma

UPDATED

Hanover 30625

Patients are needed to participate in a clinical research study of Nivolumab, Ipilimumab and Placebo to evaluate Renal Cell Carcinoma

Korea, Republic of

UPDATED

Seoul 4130

Patients are needed to participate in a clinical research study evaluating Pembrolizumab for the treatment of Renal Cell Carcinoma

Poland

UPDATED

Warsaw

Patients are needed to participate in a clinical research study evaluating Pembrolizumab for the treatment of Renal Cell Carcinoma

Russian Federation

UPDATED

Moscow

Patients are needed to participate in a clinical research study evaluating Pembrolizumab for the treatment of Renal Cell Carcinoma

Spain

UPDATED

Madrid

Patients are needed to participate in a clinical research study evaluating Pembrolizumab for the treatment of Renal Cell Carcinoma

United Kingdom

UPDATED

Hoddesdon

Patients are needed to participate in a clinical research study evaluating Pembrolizumab for the treatment of Renal Cell Carcinoma